Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The United States healthcare advertising market value reached around USD 24.70 Billion in 2025. The shift towards digital advertising is significant, as healthcare providers increasingly use online platforms to reach patients directly.
The growing emphasis on patient education and awareness about health issues also drives advertising expenditures, with healthcare organisations investing in campaigns that inform consumers about available treatments and preventive measures. The rise of telemedicine and mobile health applications further supports this trend by enabling providers to reach underserved populations. As a result, the industry is expected to grow at a CAGR of 4.00% during the forecast period of 2026-2035 to attain a value of USD 36.56 Billion by 2035.
Base Year
Historical Period
Forecast Period
In 2022, total healthcare spending in the U.S. reached USD 4.5 trillion, translating to approximately USD 13,493 per person. This high level of expenditure underscores the critical need for effective advertising strategies that inform consumers about available services and treatment options, thereby enhancing patient engagement and awareness.
The Federal government was the largest source of healthcare funding in 2022, which influences the dynamics of healthcare advertising as public health initiatives often require robust communication strategies to reach diverse populations. As healthcare providers and organisations navigate this landscape, advertising becomes essential for promoting services funded by government programs, ensuring that citizens are aware of their options.
Moreover, according to the Census Bureau, there are notable gaps in health insurance coverage by race and ethnicity, highlighting a pressing need for targeted healthcare awareness and advertising campaigns aimed at the uninsured. This demographic gap creates opportunities for healthcare marketers to develop messages that addresses specific community needs.
The report gives a detailed analysis of the following key players in the healthcare advertising market in the United States, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds. Several companies are adopting AI and machine learning to create more personalised and effective marketing strategies that can aid United States healthcare advertising demand. They are deploying AI chatbots and conversational AI to engage with both patients and healthcare professionals (HCPs) as these tools allow for deeper interactions between HCPs and pharmaceutical companies.
Johnson & Johnson, Inc
Established in 1886, this company is a prominent multinational corporation known for its diverse offerings in pharmaceuticals, medical devices, and consumer health products. The company offers an extensive portfolio that includes items ranging from baby care and skincare to high-end medical devices, making it one of the largest healthcare enterprises worldwide, and contributing to the United States healthcare advertising industry revenue.
Pfizer Inc
Pfizer, founded in 1849, is one of the leading global pharmaceutical companies headquartered in the United States. It is known for its groundbreaking contributions to medicines, vaccines, and therapeutic solutions, The company gained significant recognition for its role in the development of the COVID-19 vaccine in partnership with BioNTech.
Merck & Co., Inc
Merck & Co., Inc., also known as MSD outside the U.S. and Canada, was established in 1891 and ranks among the largest pharmaceutical firms globally. The company specialises in prescription medications, vaccines, biological therapies, and products for animal health, which can boost the growth of the United States healthcare advertising market.
Other major players in the market are GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, and Bristol- Myers Squibb Company, among others.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2025, the market reached an approximate value of USD 24.70 Billion.
The market is assessed to grow at a CAGR of 4.00% between 2026 and 2035.
The market is estimated to witness healthy growth in the forecast period of 2026-2035 to reach a value of around USD 36.56 Billion by 2035.
The major drivers of the market are rising advertisements for drugs, growth opportunities offered to several pharmaceutical marketers, and the rising number of health-conscious consumers in the country.
The key trends guiding the growth of the market include the rise of multichannel marketing and targeting consumers with local advertising.
Pharmaceuticals (small molecule drugs) advertising market, biopharmaceuticals market, vaccines market, and over-the-counter drugs market are the various product types in the market.
In the United States, the goal of healthcare advertising is to increase awareness regarding specific health issues and conditions as well as about the availability of procedures and drugs in the country.
The major players in the United States healthcare advertising market are Johnson & Johnson Services, Inc, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, and Bristol- Myers Squibb Company, among others.
Datasheet
One User
USD 2,499
USD 2,249
tax inclusive*
Single User License
One User
USD 3,999
USD 3,599
tax inclusive*
Five User License
Five User
USD 4,999
USD 4,249
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124